The Valley Desk

NCT03126916 · Interventional trial

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Overall registry status Recruiting

Phase 3

Conditions Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov